Authors


Mark O'Leary

Latest:

Introducing a New Tablet Computer for Docs

The PhreesiaPad is a tablet that lets practice increase collections, capture clear and legible patient documentation, and enhance clinical care & productivity.



Robert S. Gillespie, MD, MPH

Latest:

Management of Nephrotic Syndrome in Children

Nephrotic syndrome is a common disease in children. Minimalchange disease remains the most frequent cause, but a careful evaluation to exclude other renal conditions is important, particularly to distinguish between isolated nephrotic syndrome and nephrotic syndrome with nephritis. Corticosteroids and sodium restriction form the mainstay of therapy. Although most patients with isolated nephrotic syndrome recover quickly without major sequelae, the physician must remain alert for signs and symptoms of serious complications. Detailed patient and family education, along with close follow-up and support, will help ensure the best outcomes.








Jay Tiongson, MD

Latest:

Asystole during sleep in a 46-year-old male athlete

A number of electrocardiographic abnormalities have been described in athletes.1 Among these are sinus bradycardia and varying degrees of atrioventricular (AV) block. These findings have been attributed to the "athlete's heart," and are felt to be due to enhanced vagal tone seen with excellent physical conditioning. Secondarily it has also been suggested that there are intrinsic changes within the sinoatrial and AV nodes themselves, including prolonged sinus node recovery time and AV nodal Wenckebach, and these abnormalities persist following autonomic blockade.


Emil M. deGoma, MD1

Latest:

Are HDL cholesterol levels clinically significant in patients with low LDL cholesterol levels?

There is some debate about whether the risk of cardiovascular events associated with low high-density lipoprotein (HDL) cholesterol levels is attenuated by very low low-density lipoprotein (LDL) cholesterol levels (< 60 mg/dL), which can be obtained with statins and combination therapy.


From the 1Department of Cardiology, Ullevaal University Hospital, O

Latest:

Impact of diabetes development on atrial fibrillation in hypertensive patients

Patients with new-onset diabetes mellitus in the VALUE (Valsartan Antihypertensive Long-term Use Evaluation) trial had an increased incidence of atrial fibrillation compared with patients without diabetes. Clustering of risk factors or the presence of dysglycemia may make the heart more susceptible to arrhythmias.






Steven P. Dunn, PharmD

Latest:

Vernakalant: Expanding the antiarrhythmic vernacular

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, occurring in over 2% of the general population.




Ed Rabinowitz, Photography by Shivani Parmar, MPH

Latest:

Against all Odds

Family practitioner Jeffrey Brenner, MD, is working to reform the Camden, NJ, healthcare system one patient at a time.


Juliet Kottak Mavromatis, MD

Latest:

Part-time Women in Medicine: Are They Pulling Their Weight?

Are female physicians less ambitious than their male counterparts, or are they pursuing different professional goals that may benefit the profession in the long run?


Luigi Tavazzi, MD2

Latest:

Antithrombotic treatment of high-risk elderly patients hospitalized with atrial fibrillation

We assessed the pattern of use and the effectiveness of antithrombotic therapy in a cohort of high-risk elderly patients hospitalized for atrial fibrillation, with data derived from prescription, hospitalization, and mortality databases from 3 linked registries. Results showed that antithrombotic therapy was underused, even in patients with no comorbid conditions. In addition, patients exposed to antithrombotic therapy had a significantly lower mortality rate. The collection of epidemiological data by record linkage represents a flexible and readily available tool for monitoring and improving routine clinical care.


Miechia A. Esco MD, PhD, RPVI, FACS

Latest:

Finding Balance Again in Medicine

For healthcare executives at all levels, addressing burnout is an urgent priority, one directly impacting their overall mission of improving quality of care and patient experience as well as retaining physicians and advanced practitioners.



Sander J. Robins, MD

Latest:

Lipoprotein particle numbers: A better index of coronary events than lipoprotein cholesterol?

In a case-control substudy of the Veterans Affairs High-Density Lipoprotein Intervention Trial, therapy with gemfibrozil was shown to reduce the total number of low-density lipoprotein (LDL) particles, especially small, more oxidizable LDL particles, which was associated with a reduced risk of coronary heart disease (CHD) events. Gemfibrozil also increased small-sized high-density lipoprotein particle numbers, which also correlated with a decrease in CHD events. Notably, these changes in particle numbers were not associated with significant changes in lipoprotein cholesterol concentrations, which current guidelines have made the principal target of lipid therapy.


Michael Turner, MD

Latest:

Learning from the COVID-19 Experience: Strategies to Continue Care

Telehealth capabilities are crucial during the COVID-19 pandemic.


Adam Nadelson, MD

Latest:

Can Prebiotics and Probiotics Really Improve Gastrointestinal Health?

Prebiotics and probiotics have been discussed frequently in the media for supposedly improving overall health, especially diseases related to the gut. However, the evidence on the efficacy and use of these dietary supplements is rather complicated.


Candyce H. Stapen

Latest:

Sol Searching: Luxury and Adventure Await at Mexico's Riviera Maya and Cozumel

From a cliffside castillo to a trio of eco-adventure parks, the 85-mile stretch along Mexico's Caribbean coast offers a wide range of fun in the sun for adventurous travelers, and luxurious splendor for those looking to get away from it all.



© 2024 MJH Life Sciences

All rights reserved.